HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14.

Abstract
Mutant p53 (mutp53) proteins promote tumor invasion and metastasis in pancreatic ductal adenocarcinoma (PDAC). However, the mechanism underlying sustained activation of mutp53 oncogenic signaling is currently unclear. In this study, we report that NOP14 nucleolar protein (NOP14) expression is upregulated in PDAC tumors and metastatic tissue specimens. NOP14 overexpression promoted cell motility, whereas NOP14 inhibition decreased invasive capacity of PDAC cells. In vivo invasion assays conducted on established subcutaneously, orthotopically, and intravenously injected tumor mouse models also indicated NOP14 as a promoter of PDAC metastasis. Mechanistically, mutp53 was validated as a functional target of NOP14; NOP14 primed tumor invasion and metastasis by increasing the stability of mutp53 mRNA. The NOP14/mutp53 axis suppressed p21 expression at both the transcriptional and posttranscriptional levels via induction of miR-17-5p in PDAC cells. In vivo, high NOP14 expression in PDAC patient tumors correlated with local metastasis and lymph invasion. Overall, our findings define a novel mechanism for understanding the function of NOP14 in the metastatic cascade of PDAC. Targeting NOP14 allows for effective suppression of tumor invasion in a mutp53-dependent manner, implicating NOP14 inhibition as a potential approach for attenuating metastasis in p53-mutant tumors. Cancer Res; 77(10); 2661-73. ©2017 AACR.
AuthorsYongxing Du, Ziwen Liu, Lei You, Pengjiao Hou, Xiaoxia Ren, Tao Jiao, Wenjing Zhao, Zongze Li, Hong Shu, Changzheng Liu, Yupei Zhao
JournalCancer research (Cancer Res) Vol. 77 Issue 10 Pg. 2661-2673 (05 15 2017) ISSN: 1538-7445 [Electronic] United States
PMID28280038 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2017 American Association for Cancer Research.
Chemical References
  • Biomarkers
  • MIRN17 microRNA, human
  • MicroRNAs
  • NOP14 protein, human
  • Nuclear Proteins
  • Tumor Suppressor Protein p53
Topics
  • Animals
  • Biomarkers
  • Cell Line, Tumor
  • Cell Movement (genetics)
  • Cluster Analysis
  • Disease Models, Animal
  • Disease Progression
  • Gene Expression
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Heterografts
  • Humans
  • Mice
  • MicroRNAs (genetics)
  • Models, Biological
  • Mutation
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Nuclear Proteins (antagonists & inhibitors, metabolism)
  • Pancreatic Neoplasms (genetics, metabolism, pathology)
  • RNA Interference
  • RNA Stability
  • Signal Transduction
  • Tumor Burden
  • Tumor Suppressor Protein p53 (genetics, metabolism)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: